Skip to main content

Table 3 Final population pharmacokinetic model estimates and bootstrap results

From: Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data

Parameter

Estimated mean

RSE %

Bootstrap mean

95% CI

Population value

 CL/F, L/h

6.209

2.830

6.215

6.207–6.223

 CLCR on CL/F

0.409

9.491

0.415

0.412–0.417

 Amiodarone on CL/F

−0.238

3.158

−0.243

−0.246 – − 0.241

 Vd/F, L/kg (fixed)

6.000

NA

6.000

NA

 ka, h−1 (fixed)

1.000

NA

1.000

NA

Interindividual variability

 ωCL/F, %

34.4

2.9

34.2

34.1–34.4

Intraindividual variability

 Multiplicative, %

36.6

3.2

36.5

34.3–38.9

  1. CI confidence interval, CLCR creatinine clearance, CL/F oral clearance, ka absorption rate constant, NA not available, RSE relative standard error, Vd/F apparent volume distribution
  2. The final model parameters were as follows
  3. CL/F = 6.2 × (CLcr/60)0.41 × (1 − 0.24 × [if amiodarone])
  4. Vd/F = 6.0 × Body weight
  5. ka = 1.0